Zenas BioPharma Inc. (ZBIO)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 663 |
| % of all portfolios: | 0.003% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
6 |
$1,111,375 |
| Sells |
0 |
$0 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 19 Feb 2025 |
MOULDER LEON O JR |
Chief Executive Officer |
18 Feb 2025 |
25,000 |
6.67 |
166,750 |
| 11 Feb 2025 |
XIAO TING |
Director |
07 Feb 2025 |
10,000 |
7.76 |
77,600 |
| 04 Dec 2024 |
MOULDER LEON O JR |
Chief Executive Officer |
04 Dec 2024 |
45,000 |
9.98 |
449,100 |
| 04 Dec 2024 |
MOULDER LEON O JR |
Chief Executive Officer |
03 Dec 2024 |
25,000 |
10.76 |
269,000 |
| 20 Nov 2024 |
MOULDER LEON O JR |
Chief Executive Officer |
19 Nov 2024 |
2,500 |
14.57 |
36,425 |
| 20 Nov 2024 |
MOULDER LEON O JR |
Chief Executive Officer |
18 Nov 2024 |
7,500 |
15.00 |
112,500 |
| 20 Sep 2024 |
MOULDER LEON O JR |
Chief Executive Officer |
20 Sep 2024 |
2,367 |
17.88 |
42,322 |
| 20 Sep 2024 |
MOULDER LEON O JR |
Chief Executive Officer |
20 Sep 2024 |
2,633 |
18.97 |
49,948 |
| 20 Sep 2024 |
MOULDER LEON O JR |
Chief Executive Officer |
19 Sep 2024 |
5,000 |
17.89 |
89,450 |
| 20 Sep 2024 |
MOULDER LEON O JR |
Chief Executive Officer |
18 Sep 2024 |
10,000 |
17.91 |
179,100 |
| 18 Sep 2024 |
ENAVATE SCIENCES GP, LLC |
10% |
16 Sep 2024 |
882,353 |
17.00 |
15,000,001 |
| 17 Sep 2024 |
LU HONGBO |
Director |
13 Sep 2024 |
58,823 |
17.00 |
999,991 |
| 16 Sep 2024 |
ENRIGHT PATRICK G |
Director |
16 Sep 2024 |
440,000 |
17.00 |
7,480,000 |
| 16 Sep 2024 |
NUNN JASON RALEIGH |
Director |
16 Sep 2024 |
441,176 |
17.00 |
7,499,992 |
| 16 Sep 2024 |
FAIRMOUNT FUNDS MANAGEMENT LLC |
Director |
16 Sep 2024 |
300,000 |
17.00 |
5,100,000 |
| 16 Sep 2024 |
SR ONE CAPITAL MANAGEMENT, LLC |
10% |
16 Sep 2024 |
1,352,942 |
17.00 |
23,000,014 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock